AMNIOAMP-MP™
Dehydrated Dual-Layer Amniotic Membrane Allograft
CELLGENUITY DEVELOPS BIOLOGICS DESIGNED TO BE USED AS A THERAPEUTIC AGENT. FORMULATED WITH OUR PATENTED PŪRAMP PROCESS, OUR PRODUCTS ARE USED IN A WIDE RANGE OF SURGICAL AND NON-SURGICAL APPLICATIONS.
AmnioAMP-MP™ is a membrane allograft that may be used as a therapeutic active barrier agent in numerous clinical applications. The membrane forms a protective covering over the wound to preserve tissue structure and biologic integrity.
What Is AMNIOAMP-MP™
AmnioAMP-MP is a chorion-free, dual-layer dehydrated human amnion membrane allograft designed to protect soft tissue and support natural healing. Derived from the amniotic lining of healthy, full-term placental donations, it provides a biologically active barrier that helps shield the wound from the external environment while maintaining the qualities of native extracellular matrix (ECM).
Processed using minimally manipulated techniques, AmnioAMP-MP preserves key structural proteins and naturally hydrates in place. It can be applied in any orientation and conforms quickly to the wound bed, making it a versatile option for clinicians managing acute and chronic wounds.
Why Bobber Biotech Supplies AmnioAMP-MPP™
AmnioAMP-MP is produced under rigorous compliance frameworks, including FDA and AATB guidelines, and adheres to industry-standard safety practices from donor screening through final packaging.
Key Advantages Include:
Sourced from healthy donors after full-term delivery
Minimally manipulated processing to retain native ECM composition
Ready to use - no up-front preparation required
Ambient temperature storage
Hydrates naturally and stays in place without complex fixation
Join Us in Advancing Wound Care
Bobber Biotech, we focus on providing advanced biologic solutions backed by strong safety, consistency, and tissue-processing standards. We partner with trusted, accredited placental tissue processors to supply reliable amniotic membrane products that meet stringent regulatory guidelines.
AmnioAMP-MP aligns with our commitment to high-quality allografts that support tissue repair, reduce application challenges, and give clinicians confidence in both performance and safety.
